98%
921
2 minutes
20
Cranial irradiation for the treatment of brain cancer elicits progressive and severe cognitive dysfunction that is associated with significant neuropathology. Radiation injury in the CNS has been linked to persistent microglial activation, and we find upregulation of pro-inflammatory genes even 6 weeks after irradiation. We hypothesize that depletion of microglia in the irradiated brain would have a neuroprotective effect. Adult mice received acute head only irradiation (9 Gy) and were administered a dietary inhibitor (PLX5622) of colony stimulating factor-1 receptor (CSF1R) to deplete microglia post-irradiation. Cohorts of mice maintained on a normal and PLX5662 diet were analyzed for cognitive changes using a battery of behavioral tasks 4-6 weeks later. PLX5622 treatment caused a rapid and near complete elimination of microglia in the brain within 3 days of treatment. Irradiation of animals given a normal diet caused characteristic behavioral deficits designed to test medial pre-frontal cortex (mPFC) and hippocampal learning and memory and caused increased microglial activation. Animals receiving the PLX5622 diet exhibited no radiation-induced cognitive deficits, and exhibited near complete loss of IBA-1 and CD68 positive microglia in the mPFC and hippocampus. Our data demonstrate that elimination of microglia through CSF1R inhibition can ameliorate radiation-induced cognitive deficits in mice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981848 | PMC |
http://dx.doi.org/10.1038/srep31545 | DOI Listing |
Brain Sci
July 2025
Department of Brain and Neuroscience, Tokyo Metropolitan Institute of Medical Science, Setagaya 156-8506, Japan.
Murine microglia exhibit rapid self-renewal upon removal from the postnatal brain. However, the signaling pathways that regulate microglial repopulation remain largely unclear. To address this knowledge gap, we depleted microglia from mixed glial cultures using anti-CD11b magnetic particles and cultured them for 4 weeks to monitor their repopulation ability in vitro.
View Article and Find Full Text PDFWorld J Diabetes
August 2025
Institution of Compared Medicine, Yangzhou University, Yangzhou 225009, Jiangsu Province, China.
This letter critically comments on the article by Zheng investigating the role of aucubin in alleviating diabetic neuropathic pain (DNP). DNP arises from hyperglycaemia-induced nerve injury and microglial reprogramming toward aerobic glycolysis. Aldose reductase (also known as AKR1B1) redirects excess glucose flux through the polyol pathway, thus increasing oxidative stress and inflammation.
View Article and Find Full Text PDFSignal Transduct Target Ther
August 2025
Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedics, School of Medicine, Tongji Hospital affiliated with Tongji University, School of Life Science and Technology, Tongji University, Shanghai, China.
Scarring is an insurmountable obstacle for axonal regeneration in recovery from spinal cord injury (SCI). It impedes the repair effects of therapeutic targets in cortical neurons, such as PTEN and hyper-IL-6, which cannot break through dense scar barriers to reconstruct neural circuits. However, methods for eliminating this process remain elusive.
View Article and Find Full Text PDFTransl Psychiatry
August 2025
Mental Health Center and Institute of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Sleep loss is a key trigger for a manic episode of bipolar disorder (BD), but the underlying microglial and molecular mechanisms remain unclear. Sleep loss induces microglial and inflammatory responses. Microglia, resident macrophages in the central nervous system, regulate synaptic pruning by engulfing dendritic spines.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Department of Psychiatry, Ganzhou People's Hospital, Ganzhou, Jiangxi, China. Electronic address:
Major depressive disorder (MDD) represents a prevalent psychiatric health problem with typically neuroinflammation and microglial overactivation. Efficiently delivering therapeutic medications across the blood-brain barrier for neuroinflammation depletion remains currently unavailable. Hence, we developed the biomineralized silk fibroin nanoparticles (CaSF@TB) for intranasal delivery of tetrahydroxystilbene glucoside and berberine to target the brain in addressing depressive disorders.
View Article and Find Full Text PDF